Ciox & LabCorp Partner to Form COVID-19 Patient Registry
Ciox Health and LabCorp recently announced an agreement to collaborate on a comprehensive U.S.-based COVID-19 patient data registry. This registry will house curated, HIPAA-compliant de-identified data sets to expedite clinical research and analyses related to COVID-19.
The registry is set to scale over the coming weeks and months to aggregate millions of data points relevant to the continued study of this mission-critical area of medicine and public health. It is expected to enable researchers to better understand and characterize COVID-19 diagnoses and treatments, as well as generate insights that will aid ongoing and future pandemic preparedness and prevention efforts.